Effectiveness of a Knee Brace When Combined With Viscosupplementation in the Treatment of Knee Osteoarthritis

NCT ID: NCT01478386

Last Updated: 2013-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis: Viscosupplementation when combined with an off-loading knee brace is more effective in treating the symptoms of knee OA then treating with viscosupplementation alone

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized prospective study to assess the effectiveness of treating knee osteoarthritis with either a series of three viscosupplementation injections, an off-loading knee brace, or a combination of viscosupplementation and an off-loading knee brace. The viscosupplementation and off-loading knee brace are being used in accordance with their FDA approval. Subjects will be randomized to 1 of 3 treatment groups. The control group will receive a series of weekly (3 consecutive weeks) intra-articular hyaluronic acid injections. The second group will receive a series of weekly (3 consecutive weeks) intra-articular hyaluronic acid injections and an off loading knee brace. The third group will use the off loading knee brace alone. Subjects will complete the WOMAC Osteoarthritis Questionnaire (pain, stiffness, function) and VAS pain scale (measuring pain on movement) at baseline, day 7, day 14, 6 weeks and 3 months. Subjects in group 2 and 3 will be given a brace diary to record compliance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Viscosupplementation injections

Control group will receive a series of three viscosupplementation injections into the affected knee

Group Type OTHER

Orthovisc

Intervention Type OTHER

Subjects will receive a series of three Orthovisc injections into their affected knee

Off-loading knee brace

Group Type EXPERIMENTAL

DonJoy HA lite knee brace

Intervention Type DEVICE

Subjects will be fitted and educated on using the DonJoy HA lite knee brace to treat their affected knee

Viscosupplementation and knee brace

Group Type EXPERIMENTAL

Orthovisc injections and DonJoy HA lite knee brace

Intervention Type DEVICE

Subjects will receive a series of three Orthovisc injections and be fitted and educated on using a DonJoy HA lite knee brace

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Orthovisc

Subjects will receive a series of three Orthovisc injections into their affected knee

Intervention Type OTHER

DonJoy HA lite knee brace

Subjects will be fitted and educated on using the DonJoy HA lite knee brace to treat their affected knee

Intervention Type DEVICE

Orthovisc injections and DonJoy HA lite knee brace

Subjects will receive a series of three Orthovisc injections and be fitted and educated on using a DonJoy HA lite knee brace

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects, over the age of 18, with a diagnosis of knee osteoarthritis which is confirmed by radiographs.
* Radiographs will be obtained and patients with mild to moderate knee osteoarthritis will qualify a subject for enrollment.
* Subjects will also have a documented varus deformity.

Exclusion Criteria

* Subjects with severe arthritis as demonstrated by radiographs.
* In addition those subjects with a known or suspected joint infection and subjects who had undergone arthrocentesis and/or intra-articular injection within 3 months of the study will be excluded.
* Female patients who are pregnant or breast feeding will also be excluded.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

OAD Orthopaedics

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William R Sterba, MD

Role: PRINCIPAL_INVESTIGATOR

OAD Orthopaedics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

OAD Orthopaedics

Warrenville, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Knee OA Treatments

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The MONOVISC Hip Osteoarthritis Study
NCT02698865 TERMINATED PHASE3